SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (751)3/27/1998 4:38:00 PM
From: Michael P. Michaud  Respond to of 9523
 
Congrats to all those in well before me!!!
Any knowledgeable folks out there know how many more years Norvasc and Zithromax have patent protection from generics??
Thanx in advance
Mike



To: BigKNY3 who wrote (751)3/28/1998 4:02:00 AM
From: James Baker  Read Replies (1) | Respond to of 9523
 
*<<<<However, the fact that it does not involve an injection like the current Vivus (VVUS 10 15/16 +3/4) drug MUSE, the new Pfizer drug makes it more desirable>>>>

INJECTION -- NOT MUSE!
BigK,
When a writer for a supposedly authoritative source just is ignorant about such an important fact concerning EDtreatment and available products (competitors) don't you have to wonder about the quality of the entire article?
Jim


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News